Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Preliminary results of the Phase 1 Lip-Re I clinical trial: biodistribution and dosimetry assessments in hepatocellular carcinoma patients treated with 188Re-SSS Lipiodol radioembolization.
Delaunay K, Edeline J, Rolland Y, Lepareur N, Laffont S, Palard X, Bouvry C, Le Sourd S, Pracht M, Ardisson V, Noiret N, Bellissant É, Garin E. Delaunay K, et al. Among authors: palard x. Eur J Nucl Med Mol Imaging. 2019 Jul;46(7):1506-1517. doi: 10.1007/s00259-019-04277-9. Epub 2019 Feb 4. Eur J Nucl Med Mol Imaging. 2019. PMID: 30715571 Clinical Trial.
Transarterial Radioembolization (TARE) Agents beyond 90Y-Microspheres.
Bouvry C, Palard X, Edeline J, Ardisson V, Loyer P, Garin E, Lepareur N. Bouvry C, et al. Among authors: palard x. Biomed Res Int. 2018 Dec 31;2018:1435302. doi: 10.1155/2018/1435302. eCollection 2018. Biomed Res Int. 2018. PMID: 30687734 Free PMC article. Review.
Personalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01): a randomised, multicentre, open-label phase 2 trial.
Garin E, Tselikas L, Guiu B, Chalaye J, Edeline J, de Baere T, Assenat E, Tacher V, Robert C, Terroir-Cassou-Mounat M, Mariano-Goulart D, Amaddeo G, Palard X, Hollebecque A, Kafrouni M, Regnault H, Boudjema K, Grimaldi S, Fourcade M, Kobeiter H, Vibert E, Le Sourd S, Piron L, Sommacale D, Laffont S, Campillo-Gimenez B, Rolland Y; DOSISPHERE-01 Study Group. Garin E, et al. Among authors: palard x. Lancet Gastroenterol Hepatol. 2021 Jan;6(1):17-29. doi: 10.1016/S2468-1253(20)30290-9. Epub 2020 Nov 7. Lancet Gastroenterol Hepatol. 2021. PMID: 33166497 Free article. Clinical Trial.
Trans-arterial Radioembolization Dosimetry in 2022.
Garin E, Guiu B, Edeline J, Rolland Y, Palard X. Garin E, et al. Among authors: palard x. Cardiovasc Intervent Radiol. 2022 Nov;45(11):1608-1621. doi: 10.1007/s00270-022-03215-x. Epub 2022 Aug 18. Cardiovasc Intervent Radiol. 2022. PMID: 35982334 Review.
A MAA-based dosimetric study in patients with intrahepatic cholangiocarcinoma treated with a combination of chemotherapy and 90Y-loaded glass microsphere selective internal radiation therapy.
Manceau V, Palard X, Rolland Y, Pracht M, Le Sourd S, Laffont S, Boudjema K, Lievre A, Mesbah H, Haumont LA, Lenoir L, Brun V, Uguen T, Edeline J, Garin E. Manceau V, et al. Among authors: palard x. Eur J Nucl Med Mol Imaging. 2018 Sep;45(10):1731-1741. doi: 10.1007/s00259-018-3990-7. Epub 2018 Mar 20. Eur J Nucl Med Mol Imaging. 2018. PMID: 29560519
23 results